"Sequential therapy with induction chemotherapy and chemoradiotherapy in pre-irradiated recurrent head and neck squamous cell carcinoma incorporating nab-paclitaxel—a commentary of the phase I trial of AFHX followed by concomitant FHX scheme"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Sequential therapy with induction chemotherapy and chemoradiotherapy in pre-irradiated recurrent head and neck squamous cell carcinoma incorporating nab-paclitaxel—a commentary of the phase I trial of AFHX followed by concomitant FHX scheme

(9). Seventy percent of patients treated with the drug combination achieved a clinical complete response (CR), and 98% showed tumor shrinkage above 50%. Click to show full abstract

(9). Seventy percent of patients treated with the drug combination achieved a clinical complete response (CR), and 98% showed tumor shrinkage above 50%.

Keywords: chemotherapy chemoradiotherapy; induction chemotherapy; pre irradiated; chemoradiotherapy pre; therapy induction; sequential therapy

Journal Title: Translational Cancer Research
Year Published: 2023

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended